National Institutes of Health (NIH)

Blinatumomab is superior to standard chemotherapy for children and young adults with high- or intermediate-risk B-cell acute lymphoblastic leukemia that has relapsed.

NIH-funded finding may alter policies at hospitals where fresh red cells are preferentially used.

Plan outlines efforts to intensify ongoing HBV research.

NIH study may inform ways to reduce male-to-female HIV transmission.

NIH experts highlight importance of addressing HIV-associated comorbidities.

NIH-funded research suggests changes in the immune system in myalgic encephalomyelitis/chronic fatigue syndrome.

Network Leads Clinical Trials that Address Antibacterial Resistance Threats

NIH-funded research examined suicide and overdose risk in the year after an emergency department visit.

NEI-led study to test safety of treatment for a form of age-related macular degeneration that currently lacks treatment.

NIH’s 2019 Monitoring the Future survey finds continuing declines in prescription opioid misuse, tobacco cigarettes, and alcohol.